Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
Status:
Completed
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
The aim of this randomized controlled trial is to determine if a nutritional supplement
containing broccoli sprout and seed extracts, a rich source of sulforaphane, is effective in
reducing core symptoms of autism spectrum disorder (ASD). The study will also explore the
safety and tolerability of a sulforaphane supplement in young men with ASD, as well as its
effects on challenging neuropsychiatric symptoms that are commonly associated with ASD, such
as hyperactivity, irritability, and repetitive movements.
Phase:
Phase 2
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
North Carolina Translational and Clinical Sciences Institute